Fig. 5.
Proportion of patients achieving a threshold change in MCD–SS total score during the double-blind treatment period. MCD–SS Multicentric Castleman’s Disease–Symptom Scale
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.